MustGrow Achieves Control of Root-Rot Disease Aphanomyces in Greenhouse Trials

Share this

12 July 2021, CanadaMustGrow Biologics Corp. is pleased to announce successful greenhouse efficacy results of its patented mustard-derived biopesticide on Aphanomyces euteiches zoospores (“Aphanomyces”) via an independent third party.  Control in greenhouse soil was recorded across a range of economic application rates.  MustGrow will advance to larger scale field tests in 2021 to be conducted under the recently-announced collaborative Canadian field trials program with NexusBioAg, a division of Univar Solutions Inc.  Study results and applicability are patent-protected under MustGrow’s existing suite of issued patents.

MustGrow’s crop protection technology has consistently demonstrated efficacious benefits similar to chemistry-based “synthetic chemical” products without the harmful safety profile often associated with some synthetic chemical products.  The development of safe and effective biopesticides will be critical for future food security and environmentally sustainable agriculture.

Greenhouse Soil Study Highlights

  • Control in greenhouse soil was recorded across a range of economic application rates.
  • Initial soil samples were infested with Aphanomyces prior to applying MustGrow’s mustard-derived TerraMG.
  • Plants treated with TerraMG were increasingly robust – in plant and root system health – commensurate with application rate

Lentil plants showing a positive dose response to MustGrow’s TerraMG biopesticide

MustGrow’s remarkably safe and effective organic biopesticide is plant-based – harnessing the mustard seed’s natural defense mechanism to control diseases, insect pests, and weeds.  This greenhouse study builds on MustGrow’s previously reported (January 2021) 100% control of Aphanomyces in laboratory tests at economic application rates within 24 hours.

Share this

Leave a Reply

Your email address will not be published.